Predictive biomarker of immune checkpoint inhibitors efficacy
Thierry Berghmans (Belgium), Luis Paz-Ares (Spain)
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Number: 7
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Thierry Berghmans (Belgium), Luis Paz-Ares (Spain). Predictive biomarker of immune checkpoint inhibitors efficacy. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: